1. Home
  2. Clinical Topics
  3. FDA approves new drug for thrombocytopenia in patients with chronic liver disease
Clinical TopicsDrugs and DevicesWeb Exclusives
drug thrombocytopenia liver disease

FDA approves new drug for thrombocytopenia in patients with chronic liver disease

On May 21, the U.S. Food and Drug Administration (FDA) approved approved Doptelet (avatrombopag) tablets to treat thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.

Read more via FDA.gov.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Poll

Recent Posts